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Abstract-The administration of the convulsant, L-methionine-dl-sulfoximine (MSO), increased hista- 
mine N-methyl transferase (E.C. 2.1.1.8) (HMT) activity in rat and mouse brain and, to a lesser extent, 
catechol-O-methyl transferase (E.C. 2.1.1.6) (COMT) activity in rat brain. The duration of this effect 
was shortened by co-administration of L-methionine. The increased HMT activity was seen in S or 
7 rat brain regions tested. L-Methionine administration had no effect on the activity of either enzyme. 
Partially purified HMT preparations from rat or guinea-pig brain exhibited no alterations in activity 
after the in uitro addition of MSO or L-methionine over a wide rangc of histamine and S-adenosyl-L- 
methionine concentrations. Rat brain COMT was equally unaffected by MSO and L-methionine. The 
in uitro inhibition of HMT and COMT by S-adenosyl-L-homocysteine was the same whether tested 
on preparations derived from MSO-treated or control animals. The data are discussed with respect 
to the possible involvbnent of aberrant methylation processes in the MSO-induccd seizure. 
THE ADMINISTRATION of the convulsant, L-methionine- 
dl-sulfoximine, to rats results in a marked and 
regionally specific decrease of the brain levels of S- 
adenosyl methionine (SAM) (SCHATZ et al., 1973; 
SCHATZ & SELLINGER, 1975). It has been known for 
some time that the joint administration of MSO and 
L-methionine prevents MSO-induced seizures (LODIN 
& KOLOUSEK, 1958; SELLINGER et al., 1968), and, more 
recently, we demonstrated that the MSO-induced 
depletion of cerebral SAM is also preventcd under 
these conditions (SCHATZ & SELLINGER, 1975). Two 
possible mechanisms which may account for the 
observed depletion of the SAM levels in brain after 
MSO are (a) an inhibition of the synthesis of SAM 
via an effect of MSO on ATP: L-methionine-S-adeno- 
syl transferase (E.C. 2.5.1.6) and (b) a stimulation of 
the utilization of SAM by one or by several members 
of the large family of cerebral methyl transferase 
enzymes. Studies from our laboratory (SCHATZ et al., 
1973) have indicated that MSO fails to affect the syn- 
thesis of SAM either in vivo or in vitro, a finding 
which agrees with the observations of L~MBARDINI 
et al. (1970), who noted that MSO serves neither as 
a substrate nor as  an inhibitor of the hepatic ATP: 
L-methionine-S-adenosyl transferase. In line with the 
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second of the above alternatives, DE RORFRTIS et a/. 
(1967) described an increase of the cerebral catechol- 
0-methyl transferase activity (E.C. 2.1.1.6) (COMT) 
after MSO, a n  observation which we undertook to 
explore in more detail, together with a n  examination 
of the effect of MSO on another methyl transferase 
enzyme of brain tissue, namely histamine-N-methyl 
transferase (E.C. 2.1.1.8) (HMT). The present report 
describes findings which lend support to the premise 
of an effect of MSO on the utilization of SAM, as 
evidenced by the selective elevation of HMT in mouse 
and rat brain after MSO, and, more specifically, in 
5 out of 7 rat brain neuroanatomical regions. In addi- 
tion, our results confirm and extend the original 
observation (DE ROBERTIS et a/., 1967) that MSO 
affects COMT in vivo and they also show that neither 
methyl transferase-stimulating effect of MSO is 
reversed when L-methionine is administered jointly 
with MSO. A preliminary report has appeared 
(SCHATZ et al., 1974a). 
MATERIAL AND METHODS 
Animals 
Adult male Sprague-Dawley rats (120-2OOg) and adult 
male Swiss Webster mice (25-32g) were obtained from 
Spartan Research Animals, Inc. (Haslett, Michigan). Adult 
male Hartley guinea-pigs (425-550 g) were from Camm 
Research (Wayne, New Jersey). 
Materials 
Histamine dihydrochloride, 3,4-dihydroxybenzoic acid, 
3-methoxy-4-hydroxybenzoic acid, S-adenosyl-L-homocys- 
teine and L-methionine-dl-sulfoximine (MSO) were 
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obtained from Sigma Chemical Co., St. Louis, Missouri; 
L-methionine, from ICN Nutritional Biochemicals (Cleve- 
land, Ohio); 1-methylhistamine dihydrochloride, from Cal- 
biochem (La Jolla, California); S-adenosyl-L-methionine 
chloride, from P-L Biochemicals, Inc. (Milwaukee, Wiscon- 
sin); radioactive S-adenosyl-~-[methyl-'~C]methionine 
(specific activity 52- 57 mCi/m-mole, from New England 
Nuclear (Boston, Massachusetts); PPO and dimethyl 
POPOP, from Packard Instrument Co., Inc. (Downers 
Grove, Illinois) and silica gel TLC plates (with fluorescent 
indicator) from EM Laboratories (Elmsford, New York). 
N-methylhistamine and N,N-dimethylhistamine were 
generously provided by Dr. W. A. M. Duncan, Smith, 
Kline and French Laboratories, Ltd., Welwyn Garden 
City, Herts, England. 
Drug treatment and tissue preparation for in vivo assays 
Rats or mice were injected intraperitoneally with saline 
(10 ml/kg), methionine (4.7 m-mole/kg), MSO (0.94 m- 
mole/kg) or both MSO and methionine, 1, 3 and 6 h prior 
to sacrifice by decapitation. For regional analyses of HMT, 
rat brains were rapidly dissected on ice (GLOWINSKI & 
IVERSEN, 1966). Whole rat or mouse brain and rat brain 
regions were homogenized in 5-10 vol. of icecold saline- 
Triton X-100 (O.l%v/v) (TAYLOR & SNYDER, 1972) and the 
homogenates were centrifuged at 50,ooOg for 10min. Ali- 
quots of these supernatants were assayed for HMT or 
COMT activity (see below). 
Tissue preparation for in vitro experiments 
Whole rat or mouse brain was homogenized in 5-10 vol. 
of icecold 0.32 M sucrose or saline-Triton X-100 (@l%) and 
50,ooOg supernatants were prepared as described in the 
above section. For some experiments, HMT was partially 
purified from rat or guinea-pig brain by the procedure of 
BROWN et al. (1959). 
Analytical 
COMT was determined according to MCCAMAN (1963) 
as modified by PORCHER & HELLER (1972) with 3,4-dihyd- 
roxybenzoic acid as substrate. After a 30min. incubation 
period the reaction was stopped by the addition of 0.2 ml 
of 3 M HCI. Ethyl acetate (6ml) was added, the tubes 
shaken for lOmin, centrifuged at 2000rev./min (GLC-1, 
Sorvall, Inc., Newton, Connecticut) for 10min and 4ml 
aliquots of the organic phase were used to measure 
radioactivity. The reaction product migrated identically 
with authentic 3-[methyl-'4C]methoxy-4-hydroxybenzoic 
acid on silica gel TLC plates in benzene:propionic acid:- 
water (2: 2: 1) (ARMSTRONG et al., 1956). Compounds were 
identilied by means of diazotized sulfanilic acid spray 
(Arms & MITCHELL, 1952), ninhydrin (025% in acetone) 
spray and the ultraviolet quenching reaction (SALVATORE 
et nl., 1971). Recovery of 3-[methyl-'4C]methoxy-4-hyd- 
roxybenzoic acid from ethyl acetate was 85%. HMT was 
assayed according to SNYDER & AXELROD (1965). Authentic 
[methyl-i4C]methylhi~tamine was prepared by this 
method, and routinely 10- M histamine was used in the 
assay, higher concentrations proving strongly inhibitory. 
The concentration of SAM was 3.2 x lo-' M. The nature 
of the product was investigated and found to be identical 
with 1-methylhistamine, by cochromatography with the 
authentic substance using silica gel TLC or paper (What- 
man No. 1) chromatography in ethanol:20% ammonia:- 
water (10: 1 : l), ethano1:diethyl ether:25% ammonia:water 
(8:10:1:2) and n-butano1:ethyl acetate:water (1:l:l). 
Compounds were identified using the ultra-violet quench- 
ing reaction and ninhydrin (0.25% in acetone) or iodine 
(1% in ethanol) sprays. The recovery of [methyl-'4C]meth- 
ylhistamine from the organic phase was 50%. All enzyme 
activity values were corrected accordingly. For counting, 
4 ml aliquots of the organic phase were transferred to vials 
containing 2 mi of ethanol and 10 ml of scintillant (0.4% 
PPO and 0.01% dimethyl POPOP in toluene) and the 
radioactivity was measured in a liquid scintillation counter 
(Unilux 11, Nuclear Chicago). Counting efficiency was 
determined by the channels ratio technique. 
Protein was measured in triplicate by the method of 
LOWRY et al. (1951) using bovine serum albumin as the 
protein standard. 
Statistical analysis 
Statistical differences between drug-treated groups and 
corresponding saline-treated animals were evaluated by the 
Student t-test. 
RESULTS 
The effect of MSO on HMT in vivo 
The administration of MSO produced a time- 
dependent increase of whole brain HMT specific acti- 
vity which was maximal (25%) at 6 h (Fig. 1). HMT 
activity was also significantly increased at 1 and 3 h 
after MSO as well as after MSO + L-methionine, but 
not after L-methionine alone. Since the HMT activity 
of rat brain is much lower than that of mouse brain 
(SCHAYER & REILLY, 1973), it appeared possible that 
the effect of MSO on HMT could only be demon- 
strable in a species with low HMT activity. To test 
this, mouse brain HMT was assayed 1, 3 and 6 h  
after MSO and, as was true for rat brain, a time- 
related increase of its specific activity, with a maxi- 
mum of 20% at 6 h, was demonstrated (Fig. 2). 
The previously uncovered regional specificity of the 
MSO-induced depletion of cerebral SAM levels 
Hours after drug 
FIG. 1. Effect of methionine or methionine sulfoximine on 
rat brain histamine-N-methyltransferase activity. 0- 
methionine (4.7 m-mol/kg), -MSO (0-94 m-mol/kg), 
A-MSO + methionine. Each point represents the % 
change (mean f s.E.M.) of from 1-7 rats in enzyme activity 
compared to the corresponding saline-treated group. Mean 
control values varied from 1.69 & 0.05 to 1.95 f 0.052 mp- 
mole methylhistamine/mg proteinh. Open symbols 
denote a significant difference from saline values at the 
005 level using the Student t-test. 
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FIG. 2. Effect of methionine sulfoximine on mouse brain 
histamine-N-methyltransferase activity. t s a l i n e  (1  0 ml/ 
kg); S M S O  (0.94m-moljkg). Values are expressed as 
mpmole methyl histamine/mg protein/h and represent the 
mean f S.E.M. of &7 mice. Open symbols denote a signifi- 
cant difference from saline values at the 0.05 level using 
the Student t-test. 
(SCHATZ & SELLINGER, 1975) prompted us to examine 
the possibility of a similar regional specificity of the 
MSO effect on rat brain HMT. Table 1 shows that 
the specific activity of HMT in control brains varied 
over a 5-fold range from a low of 0.63 nmol of methyl- 
histamine/mg of protein/h in the cerebellum to a high 
of 3.00 mpmole of methylhistamine/mg of protein/h 
in the hypothalamus. While no significant effects of 
MSO were noted at I h, HMT activity was signifi- 
cantly increased in all regions except the midbrain 
and the hypothalamus at 3 h. At 6 h the MSO-elicited 
increase remained significant in the cerebellum, the 
brainstcm, the cerebral cortex and the hippocampus, 
while it ceased to be significant in the striatum (Fig. 
3). 
The effect of MSO on COMT in vivo 
The results of an investigation of the effects of 
MSO on whole rat brain COMT activity are shown 
in Fig. 4. The activity was moderately, albeit signifi- 
cantly (8%), increased at 3 h. Thc joint administration 
of MSO + L-methionine also increased COMT acti- 
vity at 1 and 3 h: whereas, as was the case with HMT, 
injections of L-methionine alone had no effect (Fig. 
4). 
Attempts to demonstrate effects on HMT in vitro 
Two scts of experiments were conducted. (A) HMT 
TABLE I .  HMT ACTIVITY IN REGIONS OF THE RAT BRAIN 









1.75 f 0.08 
267 f 0.09 
271 f 0.09 
2.74 f 0.10 
2.91 f 0.14 
3.00 & 0.15 
Values are expressed as mpmol methylhistamine/rng 
proteinh and are means f S.E.M. of 7 rats. 
was purified from untreated rat or guinea-pig brains 
and the effect of several substances on its activity was 
tested. (B) HMT was purified in parallel from un- 
treated rats and from animals injected with a convul- 
sant dose of MSO 3 h prior to death and the effects 
of a numbcr of substances on both activities were 
compared in vitro. 
(A) The following negative findings were made: 
MSO (10 x -’ M - 10 x -’ M) had no effect on par- 
tially purified (%fold) guinea-pig or rat ( 4 5  fold) 
HMT whether assayed in the presence of optimal 
(1 x 1 0 - 5 ~ )  or suboptimal (below 1 x 1 0 - 6 ~  or 
above 1 x 1 O P 4 ~ )  concentrations of histamine with 
SAM at 3.2 x 10- M or, alternatively, over the range 
5.7 x M-3.2 x M SAM and with histamine 
at 1 x 1 0 - 5 ~ .  The extent of inhibition of purified 
rat HMT by S-adenosylhomocysteine (BAUDRY et al., 
1973) which amounted to about 45% at M SAH 
and to about 95% at 1 0 - 3 ~  SAH and which was 
independent of the concentration of histamine varying 
between 1 x 1 0 - 4 ~  and 1 x M, was not altered 
by 10-3-10-s M MSO; similarly M MSO failed 
to influence the competitive inhibition by 1 x M 
SAH of the rat brain HMT with respect to SAM 
when assayed in the presence of 1 x M histamine 
and over a range of SAM concentrations extending 
from a low of 6.4 x 1 0 - ’ ~  (HMT inhibition:86%) 
to a high of 6.4 x 1 0 - 5 ~  (HMT inhibition:245%). 
(B) Several attempts were made to show differences 
between the HMT of control and MSO-treated ani- 
mals: (a) Dialysis of high-speed supernatants obtained 
from control brains did not result in increases of 
HMT activity; (b) There was no difference in sensi- 
tivity to inhibition by SAH (5 x M-5 x lo-’ M) 
between the HMT prepared from control and MSO- 
treated brains, irrespective of the medium (0.32 M suc- 
rose vs saline-Triton X-100, TAYLOR & SNYDER, 1972) 
in which the brain homogenate was prepared or of 
the storage conditions (4°C vs -70°C) under which 
the appropriate fractions were kept. 
Attempts to demonstrate effects on COMT in vitro 
Sucrose ( 0 3 2 ~ )  or Triton x-100 (0.1%) superna- 
tants of mouse and rat brain were prepared (BROCH 
& FONNUM, 1972) and COMT activity was measured 
in the presence of and M MSO or Lmeth- 
ionine. No effect of these substances on the activity 
was noted, although, somewhat contrary to the obser- 
vations of BROCH & FONNUM (1972), COMT activity 
in the 50,OOOg sucrose supernatants of both mouse 
and rat brains was consistently higher (about 30%) 
than that associated with saline-0.1% Triton X-100 
supernatants prepared in parallel. Moreover, there 
was no difference in the sensitivity of COMT toward 
SAH inhibition (COWARD et al., 1972) between un- 
treated and MSO-treated (3 h) animals. 
DISCUSSION 
The administration of MSO, previously shown to 
modulate the cerebral levels of methionine PEWS & 
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FIG. 3. Effect of methionine sulfoximine on histamine-N- 
methyltransferase activity in rat brain regions. t s a l i n e  
(10 ml/kg), 0-MSO (0.94 m-mol/kg). CL-rebellum, 
BSbrainstem, ST-striatum, HY-hypothalamus, 
MGmidbrain,  HI-hippocampus, CX-ortex. Values 
are expressed as mpmole methylhistamine/mg protein/h 
and represent the mean f S.E.M. of regions from 6 7  rats. 
Open symbols denote a significant difference from control 
values at the 0.05 level using the Student r-test. 
cause marked and region-specific reductions of cere- 
bral SAM levels (SCHATZ & SELLINGER, 1975) alsb 
results in a time-dependent elevation of the specific 
activities of two cerebral methyltransferases, HMT 
and COMT (Figs. 1-4). Of interest was the finding 
that the elevation of HMT occurred only in those 
brain regions in which the specific activity of HMT 
was below a value of 2.75 (Table I), i.e. it did not 
involve the midbrain and the hypothalamus. The 
HMT specific activity values reported in Table 1 are 
higher than those previously reported by TAYLOR & 
SNYDER (1972) and, more recently, by SCHWARTZ et 
a/. (1973). This is because different tissue preparations 
and histamine concentrations were used in the 
various determinations. Thus, TAYLOR & SNYDER 
(1972) compared the specific activity of HMT in 
homogenates of seven regions of the rat brain and 
found the highest value, 1.05 pnole/h/g of protein, in 
the hypothalamus. A value of 2.08 pmol/h/g of protein 
was obtained, however, when the assay was carried 
out on the 50,OOOg hypothalamic supernatant and 
in the presence of low5 histamine. In agreement with 
the observations of SCHWARTZ et al. (1973), the speci- 
fic activity of HMT in the spinal cord of the rat was 
found to be about 40% lower than that of whole brain 
(Schatz, R. A. & Sellinger, 0. Z., unpublished obser- 
vations). Thus, despite some fluctuations in HMT spe- 
cific activity, as determined in different laboratories, 
its relative regional distribution reflects uniform 
agreement, with the hypothalamus exhibiting the 
highest, and the cerebellum the lowest values. 
Comparing the regional effects of MSO on the 
levels of cerebral SAM (SCHATZ & SELLINGER, 1975) 
with those on HMT (Fig. 3) reveals that in both in- 
stances the hypothalamus and the midbrain remained 
largely unaffected, while, on the contrary, all other 
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and COMT (DEGUCHI & BAKCHAS, 1971 ; CQWARD 
et al., 1972); we reasoned therefore that MSO may 
be effective in altering the sensitivity of these enzymes 
toward SAH in uitro. Our efforts to gain evidence 
for this supposition were unsuccessful, however, as 
we found no circumstances under which HMT and 
COMT inhibition by SAH could be diminished by 
MSO. As a result, it is difficult to reconcile the in 
uitro and the in vivo findings, as depicted in Figs. 
1 4 ,  except by assuming that the MSO effect in uivo 
is indirect and dependent on the structural integrity 
of the tissue and the intactness of membrane-bound 
intracellular compartments housing molecules such as 
SAM (JUDES & JACOB, 1972), SAH, HMT (SNYDEK 
et al., 1974) and COMT (PORCHER & HELLEK, 1972). 
We have considered two other explanations for the 
observed MSO-induced increase of HMT: (1) MSO 
elicits the methylation of histamine to N-methyl- 
and/or NN-dimethylhistamine, two known activa- 
tors of HMT in uitro (BAKTH et al., 1973), N-methyl- 
histamine, in addition, serving as a substrate for the 
HMT of the pig antrum mucosa (BARTH et al., 1973). 
A preliminary search for these substances has not 
been successful to date as no evidcnce for their forma- 
tion in uitro by the HMT of MSO-treated, but not 
by that of control animals, could be obtained. The 
alternate possibility, namely the formation of N -  
methylhistamine and N',N'-dimethylhistamine in 
brain after MSO remains-to be tested. (2) MSO causes 
an accelerated metabolism of SAH via activation of 
adenosylhomocysteinase (S-adenosylhomocysteine 
hydrolase, E.C. 3.3.1.1), an enzyme known to be 
engaged in the regulation of several other methyl 
transferases including hepatic COMT (DEGUCHI & 
BARCHAS, 1971). Brains of MSO-treated animals 
would thus contain less than normal amounts of 
SAH, the regulation of HMT levels by SAH would 
be temporarily relieved and hence HMT activity levels 
would rise to the observed higher than normal values. 
It is tempting to extend the relevance of the above 
considerations to help explain thc convulsant proper- 
ties of MSO. It is possible that 'abnormal' methylated 
substances such as, for example, N-methyl- and/or 
N',N'-dimethylhistamine or other as yet unidentified 
methylated amines may be the actual causative agents 
of the seizure. Alternatively, if increased breakdown 
of excess SAH is involvcd as a mechanism to return 
the MSO-perturbed cellular SAM/SAH ratios to con- 
trol values, homocysteine, a convulsant agent whose 
action results in MSO-like seizures (SPRINCE et al., 
1969), and/or homocysteic acid, a powerful CNS ex- 
citant (CURTIS et a/., 1972) could be produced at 
selected sensitive sites in amounts sufficient to trigger 
uncontrolled neuronal firing. 
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